News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Beck John W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2020 |
4
| Beck John W (CFO) has filed a Form 4 on RITTER PHARMACEUTICALS INC|
Txns:
| Granted 221,566 options to buy
@ $0.64, valued at
$141.8k
|
|
| 12/13/2019 |
4
| Beck John W (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.|
Txns:
| Granted 40,000 options to buy
@ $2.65, valued at
$106k
Granted 10,000 options to buy
@ $2.65, valued at
$26.5k
|
|
| 12/13/2019 |
3
| Beck John W (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC. |
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2018 |
4
| Beck John W (CFO) has filed a Form 4 on RITTER PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $3.32, valued at
$332k
|
|
| 05/25/2018 |
3
| Beck John W (CFO) has filed a Form 3 on RITTER PHARMACEUTICALS INC |
| 06/20/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2012 |
4
| Beck John W (SVP, Finance & Operations, CFO) has filed a Form 4 on Ardea Biosciences, Inc./DE|
Txns:
| Sold 28,048 shares
@ $31.97, valued at
$896.7k
Exercised 28,048 options to buy
@ $14.26, valued at
$400k
|
|
| 07/26/2011 |
4
| Beck John W (SVP, Finance & Operations, CFO) has filed a Form 4 on Ardea Biosciences, Inc./DE|
Txns:
| Sold 16,000 shares
@ $24.4632, valued at
$391.4k
Exercised 16,000 options to buy
@ $14.26, valued at
$228.2k
|
|
| 05/18/2011 |
4
| Beck John W (SVP, Finance & Operations, CFO) has filed a Form 4 on Ardea Biosciences, Inc./DE|
Txns:
| Granted 1,500 shares
@ $5.85, valued at
$8.8k
Exercised 1,100 shares
@ $25.3432, valued at
$27.9k
Exercised 400 shares
@ $26.0388, valued at
$10.4k
Granted 1,000 shares
@ $5.85, valued at
$5.9k
Exercised 1,000 shares
@ $25, valued at
$25k
Exercised 1,500 options to buy
@ $5.85, valued at
$8.8k
Exercised 1,000 options to buy
@ $5.85, valued at
$5.9k
|
|
| 02/16/2011 |
4
| Beck John W (SVP, Finance & Operations, CFO) has filed a Form 4 on Ardea Biosciences, Inc./DE|
Txns:
| Granted 7,500 shares
@ $5.85, valued at
$43.9k
Exercised 7,500 shares
@ $26.6116, valued at
$199.6k
Exercised 7,500 options to buy
@ $5.85, valued at
$43.9k
|
|
| 12/16/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/17/2010 |
4
| Beck John W (SVP, Finance & Operations, CFO) has filed a Form 4 on Ardea Biosciences, Inc./DE|
Txns:
| Granted 7,500 shares
@ $5.85, valued at
$43.9k
Exercised 7,400 shares
@ $22.9695, valued at
$170k
Exercised 100 shares
@ $23.81, valued at
$2.4k
Exercised 7,500 options to buy
@ $5.85, valued at
$43.9k
|
|
| 12/18/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 05/21/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 12/19/2008 |
4
| Beck John W (SVP, Finance & Operations, CFO) has filed a Form 4 on Ardea Biosciences, Inc./DE |
|
|